Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema

The aim of this review will be to assess the efficacy and safety of intravitreal agents to counter vascular endothelial growth factor (anti-VEGF agents) combined with intravitreal steroids for the management of diabetic macular oedema in comparison to monotherapy with either macular laser, intravitreal steroids or intravitreal anti-VEGF agents.

This is a protocol.

Share/Save